BioXcel Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GOODMAN ADVISORY GROUP, LLC | 04/25/2025 | 661 | $31.00 K | 100.00% | 0.01% |
| JPMORGAN CHASE & CO | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| US BANCORP \DE\ | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 05/09/2025 | 0 | $0 | -100.00% | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
| DAVENPORT & CO LLC | 04/28/2025 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| FEDERATED HERMES, INC. | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 05/07/2025 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 05/07/2025 | 0 | $0 | -100.00% | 0.00% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 04/22/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| PARKSIDE FINANCIAL BANK & TRUST | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/19/2025 | 0 | $0 | -100.00% | 0.00% |
| ARETE WEALTH ADVISORS, LLC | 05/16/2025 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
| ENGINEERS GATE MANAGER LP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| SEACREST WEALTH MANAGEMENT, LLC | 04/11/2025 | 0 | $0 | -100.00% | 0.00% |
| 05/02/2025 | 0 | $0 | -100.00% | 0.00% | |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 04/10/2025 | 0 | $0 | -100.00% | 0.00% |
| WASHINGTON TRUST ADVISORS, INC. | 04/25/2025 | 0 | $0 | -100.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 04/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK, INC. | 05/02/2025 | 0 | $0 | -100.00% | 0.00% |
| POINT72 (DIFC) LTD | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| DIVERSIFY WEALTH MANAGEMENT, LLC | 05/01/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioXcel Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 56 institutional investors and hedge funds held shares of BioXcel Therapeutics, Inc.. The most heavily invested institutionals were:
Goodman Advisory Group, LLC: 661
JPMORGAN CHASE & CO: 0
Federation des caisses Desjardins du Quebec: 0
STATE STREET CORP: 0
Squarepoint Ops LLC: 0
DAVENPORT & Co LLC: 0
0.01% of BioXcel Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 449.92 K shares in the last 24 months. This purchase volume represents approximately $566.90 K in transactions.